Undue Extension of Hospital Stay Associated With Anticoagulation
- Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin. Konduru, Sai; Cheema, Aamir; Jones, Philip; Li, Yan; Ramza, Brian; Wimmer, Alan // Journal of Interventional Cardiac Electrophysiology;Dec2012, Vol. 35 Issue 3, p277
Purpose: Effective intraprocedural anticoagulation for catheter ablation for atrial fibrillation is critical to minimize the risk of cerebral thromboembolism. The effect of dabigatran on anticoagulation with heparin during the procedure is unknown. This study compares heparin anticoagulation in...
- warfarin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p800
An encyclopedia entry for the term "warfarin" is presented. It refers to an anticoagulant drug administered for the prevention and treatment of abnormal blood clotting. It can also be used to treat deep vein thrombosis, pulmonary embolism or atrial fibrillation The entry notes that there is need...
- Study backs warfarin option. // Pulse;11/3/2010, Vol. 70 Issue 33, p8
The article reports on a study based on Great Britain's prices of dabigatran which shows that oral anticoagulants could be cost effective alternatives to warfarin for atrial fibrillation.
- Risk of bleeding with dabigatran found in 'real-world' patients. // Pulse;Dec2014, p21
The article offers information on the findings of a study which investigates the effect of warfarin and dabigatran in patients who are diagnosed with atrial fibrillation.
- Erratum to: Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice. Gonzalez-Quesada, Carlos; Giugliano, Robert // American Journal of Cardiovascular Drugs;Jun2014, Vol. 14 Issue 3, p237
Corrections are presented to articles published online in the April 29, 2014 issue on topics including dosage for the drugs dabigatran and apixaban and the dosage of aspirin.
- Thrombophilia and Recurrent DVT. Artz, Andrew S. // Clinical Oncology Alert;Sep2009, Vol. 25 Issue 9, p68
WARFARIN IS AN EFFECTIVE AND INEXPENSIVE ORAL anticoagulation therapy used to prevent both venous and arterial thromboembolism. However, the narrow therapeutic window requires frequent monitoring, typically measured by the international normalized ratio (INR). Stable and long-term control of INR...
- Increased risk of ischaemic stroke while initiating warfarin in patients with atrial fibrillation. ADHIYAMAN, VEDAMURTHY; O'MAHONY, KEIRAN // Clinical Medicine;Apr2015, Vol. 15 Issue 2, p215
A letter to the editor is presented in response to the article "Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes" by L. Azoulay in the previous issue.
- Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes. Benavente, Lorena; Calleja, Sergio; de la Vega, Vanessa; García, Jorge; Lahoz, Carlos H. // International Archives of Medicine;2010, Vol. 3, p8
Background: Stroke incidence increases with age. Atrial fibrillation (AF) is an important risk factor for ischemic stroke and its incidence also increases with age. However oral anticoagulant therapy (OAT) tends to be underused in the elderly population. Methods: Elderly patients (> = 80 years)...
- Cancer and thrombosis: implications of published guidelines for clinical practice. Khorana, A. A. // Annals of Oncology;Oct2009, Vol. 20 Issue 10, p1619
Cancer is a frequent finding in patients with thrombosis, and thrombosis is much more prevalent in patients with cancer, with important clinical consequences. Thrombosis is the second most common cause of death in cancer patients. Venous thromboembolism (VTE) in cancer is also associated with a...